Japan, Feb. 18 -- PROTAGONIST THERAPEUTICS INC has got intellectual property rights for 'PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND USE THEREOF FOR TREATING INFLAMMATORY DISEASES.' Other related details are as follows:

Application Number: JP,2022-193564

Category (FI): A61K38/08,A61K38/10,A61K38/20,A61K47/54,A61K47/56,A61K47/60,A61K9/28,A61K9/72,A61P1/00,A61P1/04,A61P1/16,A61P1/18,A61P11/06,A61P17/06,A61P3/10,A61P37/06,A61P43/00,111,C07K14/00,C07K7/50,C12N15/11@Z,C12N15/63@Z

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 2, 2022

Publication Date: Jan. 26, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....